Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

NCT03867318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

621

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Atorvastatin
DRUG: Ezetimibe
DRUG: Placebo for Ezetimibe
DRUG: Placebo for Atorvastatin

Sponsor

Organon and Co